pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid has been researched along with Diabetes Mellitus in 1 studies
pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid: a novel antagonist that selectively blocks P2 purinoceptor receptors; a useful tool to study co-transmission in tissues when ATP and coexisting neurotransmitters act in concert
5'-phosphopyridoxal-6-azobenzene-2,4-disulfonic acid : An arenesulfonic acid that is pyridoxal 5'-phosphate carrying an additional 2,4-disulfophenylazo substituent at position 6.
Diabetes Mellitus: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Karczewska, J | 1 |
| Piwkowska, A | 1 |
| Rogacka, D | 1 |
| Stępiński, J | 1 |
| Angielski, S | 1 |
| Jankowski, M | 1 |
1 other study available for pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid and Diabetes Mellitus
| Article | Year |
|---|---|
Purinergic modulation of glucose uptake into cultured rat podocytes: effect of diabetic milieu.
Topics: Adenosine Triphosphate; Animals; Biological Transport; Cells, Cultured; Deoxyglucose; Diabetes Melli | 2011 |